mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |